The only information I have seen is a transcript from a recent investors conference. The CEO stated the next gen program was moving along nicely. There may be other programs outside of CF, I'm just not aware of specifics.
without info on the non-cf pipeline it is not possible to give a substantiated guess on a buy-out offer. My wild guess is somewhere between $170 and $200 - if an offer will be made, which I doubt.
I hate people who post other socks on this board,,,,,but I have to say if you bought it a week ago you hit a grand slam!!!!!!!!!!!!!!!!!!!!!!!
Sentiment: Strong Buy
Hostile takeover bid currently proposed by Shire for Baxalta. The offer seems like a relatively small premium from the current price. If a larger pharma wanted VRTX, the offer would need to give a greater value for the potential of the Vertex pipeline, both CF and non-CF assets. Daily articles in the media coming out about potential takeover bids of VRTX. Today's market action suggests that this time it may be really happen. Any guesses as to the amount a potential buyer would pay in a buyout offer? A proposed buyout would be more likely to be a hostile takeover requiring a shareholder vote, given VRTX management's long-term vision to be a large independent biotech company. How high a price would be needed to win a takeover vote put to VRTX shareholders?
You are crazy. If it is a public company, salary is determined by the board of directors. The CEO does not have the pay himself anything.
All the recent talk and rumors about companies interested in buying Vertex indicates how highly valuable Vertex is in the eye of biotech analysts.
how about biogen buys vertex, and then gilead buys biogen! win win!
these stories are always good for a short term pop but go nowhere